Trial Profile
Phase I study of ORY-2001 in patients with Huntington's disease
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2016
Price :
$35
*
At a glance
- Drugs Vafidemstat (Primary)
- Indications Huntington's disease
- Focus Adverse reactions
- 04 Nov 2016 New trial record